The changing nature of health research could drive a surge in demand for high-quality office space in Scotland’s cities from the burgeoning life sciences sector, according to Knight Frank.
There is a growing collaboration between companies in the industry and the wider tech sector, along with a shift toward computational science, that will cause seismic shifts in the industry’s property requirements.As medical technology, biopharmaceutical and digital health companies become more interdependent, property will need to reflect their growing need to “cluster” together in new locations. The report highlighted the £750 million (€850 million/$698 million) expansion plans at Edinburgh’s BioQuarter and the establishment of the Medicines Manufacturing Center in Renfrewshire as examples of the trend already taking hold in Scotland.
Knight Frank’s analysis also found a strong track record of life science spinout companies emerging from Scottish higher education ins
